-
Use of an Independent Data Review Committee to Promote Best Practices for External Control Arms: A Case Study in Relapsed/Refractory Multiple Myeloma
Mar 10, 2025, 14:00 PM -
Impact of Capacity and Resource Constraints on Wet Age-Related Macular Degeneration and Diabetic Macular Edema in the Brazilian Public Healthcare System: an Individual-Level Microsimulation Study
Mar 10, 2025, 14:00 PM -
Exploring Patient Preferences for Systemic Treatments in Psoriasis: A Review of the Literature
Mar 10, 2025, 14:00 PM -
Trends in the Global Drug Development Pipeline 2024
Mar 10, 2025, 14:00 PM -
Meaningful Changes in Physical Function and Pain in Patients with K-L Grade 3 Knee Osteoarthritis
Mar 10, 2025, 14:00 PM -
The Prevalence of Fractional-Polynomial Network Meta-analyses (fpNMAs) in Supporting Reimbursement Recommendations by Canada's Drug Agency (CDA-AMC)
Mar 10, 2025, 14:00 PM -
Evolution of Technology Diffusion within Brazilian Universal Healthcare System (Sistema Único de Saúde - SUS) 2+ Years After Listing of Antiangiogenics Treatment for Age-Related Macular Edema (AMD)
Mar 10, 2025, 14:00 PM -
Estimating the Impact of Pill Burden on the Utility of Patients Undergoing Hemodialysis
Mar 10, 2025, 14:00 PM -
Patient, Caregiver, and Physician Perspectives on the Burden of Disease Chronic Refractory Gout and Its Treatment: Concept Elicitation
Mar 10, 2025, 14:00 PM -
Cost-effectiveness of Esketamine versus Real-world Treatments for Patients with Treatment-resistant Depression: A Multi-armed Modelling Study
Mar 10, 2025, 14:00 PM -
Preferences for Parkinson's Disease Treatments: A Scoping Literature Review
Mar 10, 2025, 14:00 PM -
Access and Quality of Usual Source of Care and Racial/Ethnic Disparities in US Adults with Multiple Chronic Conditions
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in Poland in Comparison With Efficacy Reported in Clinical Trials
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada
Mar 10, 2025, 14:00 PM -
Medical Costs in Patients with Pulmonary Arterial Hypertension (PAH) on Oral Triple Therapy including Selexipag in the United States (US): A retrospective Claims-Based Study
Mar 10, 2025, 14:00 PM -
Automating Health Economic Model Quality Check With a Model Generator
Mar 10, 2025, 14:00 PM -
Characteristics of Adults With Type 2 Diabetes Who Are Not Treated With A Glucose-Lowering Agent: A Retrospective Cohort Study
Mar 10, 2025, 14:00 PM -
Patient and Diagnostic Delay in Patients With Breast or Colorectal Cancer
Mar 10, 2025, 14:00 PM -
JAV-RARAS: Analysis of the Value-Driven Care Journey for Patients With Rare Diseases in Brazil Applying the Time-Driven Activity-Based Costing Methodology
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of a Potential Policy to Ban Alcohol Advertising in Australia: A Modeling Study
Mar 10, 2025, 14:00 PM
